Dr. Charles M. Rudin highlighted new small cell lung cancer therapies, including T cell engagers, antibody-drug conjugates, ...

The phase 2 SANRECO study has recently completed enrollment and will evaluate divesiran, a potential therapy for patients ...

Voranigo (vorasidenib), a drug for certain brain tumors, was safe and well toleratedin patients with grade 3 or 4 IDH-mutant ...

Sac-TMT combined with Keytruda significantly improves progression-free survival in PD-L1-positive advanced non-small cell ...

In observation of Neuroendocrine Tumors (NETs) Awareness Month, Dr. Pamela L. Kunz sat down for an interview with CURE to ...

Panelists discuss how patients beginning talquetamab should maintain a positive attitude, prepare thoroughly with educational ...

Panelists discuss how effective caregivers should join support groups, maintain detailed records of symptoms and medications, ...

Panelists discuss how healthcare providers can develop comprehensive management protocols for talquetamab-related toxicities ...

Grief intertwines with holiday traditions, creating a complex emotional landscape where joy and sorrow coexist, reflecting the depth of love and loss. The natural human process of grief is intensified ...

Panelists discuss how specific talquetamab-related side effects like skin peeling, nail changes, and rashes can be effectively managed through targeted interventions including topical treatments, ...

Panelists discuss how successful talquetamab treatment requires coordinated care between inpatient and outpatient teams, comprehensive caregiver preparation including education materials and emergency ...

Panelists discuss how Alan Plisskin's multiple myeloma diagnosis began with severe back and hip pain, progressed through life-threatening complications, including seizures and vocal cord paralysis, ...